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Objective
To use velocity encoded phase contrast MRI to deter-
mine timing of peak myocardial blood flow to establish
when CMR stress perfusion imaging should be per-
formed after injection of regadenoson.
Background
Regadenoson is a selective A2A adenosine receptor
agonist recently FDA approved for stress testing. The
package insert recommends administration of the radio-
nuclide imaging agent 20 seconds after bolus. Optimal
timing of CMR first-pass perfusion imaging has not
been established.
Methods
CMR was performed on eighteen volunteers with 10-year
Framingham risk scores <1% (15 m, 23 ± 7 years) using a
1.5 T Siemens Espree. Serial measures of coronary sinus
(CS) and cardiac output (CO) were made using a velocity
encoded phase contrast sequence.
Results
Peak CS flow occurred at 101.7 ± 69.1 seconds (median
75 seconds) which was significantly different than the
recommended injection time of 20 sec (p<0.001). Flow
at 90 seconds was also higher than at 30 seconds
(p<0.001). CS flow decreased more rapidly than systemic
flow and heart rate however none returned to baseline
by 20 min. Figs 1, 2, 3, 4.
Conclusion
Peak myocardial blood flow occurs later after injection
of regadenoson than suggested in the package insert
(median 75 or average 102 seconds vs 20 seconds).
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Figure 1 CS Flow vs. HR
Figure 2 CS Flow vs. Aortic Flow
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Figure 3 Systemic Flow
Figure 4 Rest vs. Peak vs. 20 min
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